Navigation Links
Psychiatric Drugs Might Raise Cardiac Death Risk
Date:5/14/2009

But other medical factors could also be at play, researchers note

THURSDAY, May 14 (HealthDay News) -- Preliminary research suggests people who suffered fatal cardiac arrest were more likely to have taken antidepressants and other psychiatric drugs than those who survived heart attacks.

But the findings haven't been confirmed elsewhere, and it's not clear whether the medications directly cause any problems. Those who take the drugs could have other medical issues that contribute to a higher death rate, the researchers noted.

"It is too early to give concrete advice" to patients who take the drugs, said study author Dr. Jussi Honkola, a researcher at the University of Oulu in Finland. "We need further studies about this possible relationship."

In other words, there's no indication that anyone needs to change the drugs that they take for conditions such as depression and anxiety.

At issue is sudden cardiac death -- when someone dies suddenly and unexpectedly, often within minutes, after the heart stops functioning properly. Heart attacks can lead to cardiac arrest and then sudden cardiac death. But heart attacks are technically something else -- the death of heart tissue because blood flow is disrupted.

A variety of conditions can cause sudden cardiac death, including the clogging of arteries caused by coronary heart disease.

And, "despite many years of intensive research we still don't know how to identify people who are at risk for sudden cardiac death," Honkola said.

In the new study, the Finnish researchers examined the medications taken by 321 victims of cardiac death compared with those taken by 609 patients who survived heart attacks.

The findings were to be released Thursday at the Heart Rhythm Society's annual meeting, in Boston.

The study doesn't reveal specifically which psychiatric drugs were examined, but it does say that those who died of cardiac death were more likely to have taken one of three types.

Almost 11 percent of those who suffered sudden cardiac death took antipsychotics, compared to 1.4 percent of those who survived heart attacks. The numbers for antidepressants were 7.4 percent and 3 percent, respectively, and 18.4 percent and 5 percent for benzodiazepines, which include drugs such as Xanax.

Those who survived heart attacks were more likely to take aspirin and the heart drugs known as beta blockers.

The findings "are interesting, even provocative, but much more work remains to be done in order to have a high degree of confidence in the results," said Dr. Robert A. Harrington, director of the Duke Clinical Research Institute in Durham, N.C.

"For now, society should insist upon randomized clinical trials during and after the drug approval process that test therapies in patients who will likely take the drugs in 'real life,'" Harrington said.

That means those who take part in tests of drugs represent those who ultimately take them when it comes to their medical conditions and the other drugs that they're taking, he explained.

More information

Learn more about sudden cardiac death from the American Heart Association.



SOURCES: Jussi Honkola, M.D., researcher, University of Oulu, Finland; Robert A. Harrington, M.D., professor, medicine, Division of Cardiology, and director, Duke Clinical Research Institute, Durham, N.C.; May 14, 2009, presentation, Heart Rhythm Society annual meeting, Boston


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
2. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
3. American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference
4. Psychiatric Woes Can Postpone Weight-Loss Surgery
5. NARSAD - the Worlds Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th
6. Services for patients with BPD need to be improved say psychiatric nurses
7. Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting
8. Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions
9. Child mental health experts issue psychiatric medication treatment guidelines for preschoolers
10. Treating patients with psychiatric disorders for hepatitis C
11. Relatives of Parkinsons Patients at Higher Psychiatric Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Psychiatric Drugs Might Raise Cardiac Death Risk
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: